Filing Details
- Accession Number:
- 0001104659-21-006328
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-01-21 16:31:24
- Reporting Period:
- 2021-01-20
- Accepted Time:
- 2021-01-21 16:31:24
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1773427 | Springworks Therapeutics Inc. | SWTX | Biological Products, (No Disgnostic Substances) (2836) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1787013 | Mary L. Smith | C/O Springworks Therapeutics, Inc. 100 Washington Blvd. Stamford CT 06902 | Chief Development Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-01-20 | 1,128 | $1.65 | 168,639 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2021-01-20 | 8,872 | $2.30 | 177,511 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-01-20 | 10,000 | $78.70 | 167,511 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2021-01-20 | 1,128 | $0.00 | 1,128 | $1.65 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2021-01-20 | 8,872 | $0.00 | 8,872 | $2.30 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 1,451 | 2029-03-19 | No | 4 | M | Direct | |
| 114,296 | 2029-04-22 | No | 4 | M | Direct |
Footnotes
- The stock option exercises and sale transactions reported on this Form 4 were effected pursuant to a trading plan adopted pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $77.83 to $79.24, inclusive.
- Includes 167,511 restricted stock awards which are subject to forfeiture until they vest.
- 25% of this option vested and became exercisable on March 19, 2020. The remainder vests and becomes exercisable in 36 equal monthly installments thereafter.
- This option began to vest and become exercisable in 48 equal monthly installments beginning on April 22, 2019.
Billionaire Hedge Funds
